Genentech's rise and...current precipice

Plus: As doctors urge cracking down on childhood obesity, other experts worry about the rise of eating disorders

September 16, 2024 Check out STAT+

Sponsored By

Justin Sullivan/Getty Images STAT+ | Genentech, a biotech with a storied past, confronts new turbulence in the present The closure of the company's cancer immunology group and multiple rounds of layoffs have prompted concern about its future. By Jonathan Wosen Q&A: The U.S. can, and should, do more on H5N1 bird flu, a top WHO official says The world is watching how the U.S. is responding to the H5N1 outbreak in dairy cattle, according to the WHO's Maria Van Kerkhove. By Helen Branswell STAT+ | What Medicare Advantage enrollment could look like for next year This week in healthcare news: A look at 2025 Medicare Advantage plans, breaking down medical debt relief, and the latest on Humira biosimilars. By Bob Herman Heather Ainsworth for STAT STAT+ | Pediatricians' obesity guidelines rest on shaky evidence about eating disorder risks The American Academy of Pediatrics said aggressive obesity interventions would not fuel eating disorders. The group now acknowledges evidence is limited. By Kate Raphael STAT+ | Exact Sciences reports initial positive results in colon cancer blood test, but pivot trial still pending The initial results suggest that Exact's test could be an alternative to others on the market, but the findings come from a small study. By Jonathan Wosen STAT+ | Pfizer drug shows promise in cancer-related condition that causes weight loss and weakness The company reported at the annual ESMO meeting that an experimental antibody helped cancer patients with a condition known as cachexia. By Andrew Joseph Nathan Howard/Getty Images STAT+ | Top staffer on drug pricing to depart Senate Finance Committee The Democratic staffer who drafted much of the drug pricing portion of the Inflation Reduction Act is leaving the Senate Finance Committee. By John Wilkerson and Rachel Cohrs Zhang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser